- Home
- PYPD vs LGL Comparison
PYPD vs LGL Comparison
Compare PYPD & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- LGL
- Stock Information
- Founded
- PYPD 2008
- LGL 1917
- Country
- PYPD Israel
- LGL United States
- Employees
- PYPD N/A
- LGL N/A
- Industry
- PYPD Medical/Dental Instruments
- LGL Industrial Machinery/Components
- Sector
- PYPD Health Care
- LGL Technology
- Exchange
- PYPD Nasdaq
- LGL Nasdaq
- Market Cap
- PYPD 35.3M
- LGL 35.6M
- IPO Year
- PYPD 2020
- LGL N/A
- Fundamental
- Price
- PYPD $3.44
- LGL $7.30
- Analyst Decision
- PYPD Strong Buy
- LGL
- Analyst Count
- PYPD 5
- LGL 0
- Target Price
- PYPD $11.40
- LGL N/A
- AVG Volume (30 Days)
- PYPD 1.4M
- LGL 38.9K
- Earning Date
- PYPD 08-13-2025
- LGL 08-12-2025
- Dividend Yield
- PYPD N/A
- LGL N/A
- EPS Growth
- PYPD N/A
- LGL 204.51
- EPS
- PYPD N/A
- LGL 0.08
- Revenue
- PYPD N/A
- LGL $4,322,000.00
- Revenue This Year
- PYPD N/A
- LGL N/A
- Revenue Next Year
- PYPD N/A
- LGL N/A
- P/E Ratio
- PYPD N/A
- LGL $95.56
- Revenue Growth
- PYPD N/A
- LGL 20.66
- 52 Week Low
- PYPD $2.30
- LGL $5.03
- 52 Week High
- PYPD $4.49
- LGL $9.74
- Technical
- Relative Strength Index (RSI)
- PYPD 56.85
- LGL 67.76
- Support Level
- PYPD $3.45
- LGL $6.73
- Resistance Level
- PYPD $3.62
- LGL $9.74
- Average True Range (ATR)
- PYPD 0.20
- LGL 0.96
- MACD
- PYPD -0.01
- LGL 0.09
- Stochastic Oscillator
- PYPD 63.57
- LGL 45.08
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.